This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sih-Yu Chen: Innovator in Antibody Development
Introduction: Sih-Yu Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents: Sih-Yu Chen holds a patent for "Anti-CD73 antibodies and use thereof." This invention relates to a novel antibody and its antigen-binding fragment, which specifically binds to human CD73 at designated epitopes. The patent highlights the unique complementarity-determining regions (CDRs) that characterize the antibody and its fragment, showcasing their potential applications in therapeutic settings.
Career Highlights: Sih-Yu Chen is affiliated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in antibody technology. His expertise and innovative approach have positioned him as a key figure in the biotechnology sector.
Collaborations: Throughout his career, Sih-Yu Chen has collaborated with notable colleagues, including Chun-Chung Lee and Yu-Hsun Lo. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion: Sih-Yu Chen's contributions to the field of biotechnology, particularly through his patent on anti-CD73 antibodies, demonstrate his commitment to innovation and advancement in medical science. His work continues to pave the way for future developments in antibody therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile